• Quit being a wimp about the state of Live Science Venture Capital (link)
  • Corporate VCs fill the growing life science VC gap (link)
  • VCs should first be Start-up CEO’s (link)
  • Will a VC bring in a pro-CEO once the round is closed? (link)

{ 1 comment }

PhD to Business – Lessons Learned

by jtaylor on November 11, 2011

This post was originally posted on the Nature Biotech Trade Secrets blog

The folks at Nature Biotech asked us authors for a description of how we’ve navigated our careers from bench to business.  My story is still a work in progress, but as a recent Ph.D. I do have some lessons learned of things you can do to prepare yourself for a career beyond research and into entrepreneurism.  First here’s a brief bio to give insight into my perspectives and biases:

I completed an Engineering Physics undergraduate degree at the University of British Columbia, with a focus on wireless and photonics.   During this time, I worked at my first startups as an engineer, which ultimately sewed the entrepreneurial seeds.   Following, I decided to pivot and apply my engineering skills to health and completed a Ph.D. in Genetics at the Institute for Systems Biology (ISB).  My decision to conduct a Ph.D. was driven by my interest in the commercialization of advanced technologies and the ISB was a fantastically entrepreneurial organization to pursue this goal.  Concurrent with my Ph.D., I was fortunate to work as a venture capital fellow at the ISB-affiliated venture capital firm, the Accelerator Corp.  This was a tremendously valuable experience and during my three year tenure, the Accelerator team started 7 biotech companies.  After my Ph.D., I started looking for my next startup opportunity and met my co-founding team while working at an innovative technology transfer group, the Centre for Drug Research and Development.  Approximately, 1.5 years ago I jumped ship to be a co-founder and CEO of Precision NanoSystems, where we are developing technology at the convergence of drug delivery, nanotechnology and genomics.

During my tenure as a Ph.D. student I often contemplated how to best use the degree to achieve my business goals and as you are likely realizing, the path from bench to business is not always clear.  Here are some lessons I learned during my degree that may be helpful for those wanting to pursue an entrepreneurial or business career:

Experience more than you Ph.D. offers.

Graduate or postgraduate studies are designed as a scientific training ground for a career as a scientist or professor.  The knowledge gained is narrow and the skills learned are specific.  For anyone serious about transitioning off the bench, you will need to actively pursue additional experiences and skills outside of your research work.  There are many ways to do this during your degree, and I found that volunteering at an organization in an area of interest is one of the best ways to get your feet wet.  My time at the Accelerator Corp. (which I initiated through a volunteer position) was one of the best experiences of my Ph.D. There I learned a tremendous amount about biotech, startups, and venture capital.  I was very fortunate to have a Ph.D. supervisor supportive of my entrepreneurial interests and was able to dedicate half of a day to a full day a week to the experience (in addition to most of my evenings and weekends).  If you are less fortunate, you may receive push-back from your supervisor, who may not recommend taking the time away from your thesis or papers.  However I strongly disagree.  Ph.D. and Post-doc work is highly repetitive and obtaining orthogonal experiences will greatly enrich your time as a student.  Further, your supervisor will benefit from his or her student’s success, be it in academia or industry, and should be supportive of those that demonstrate such ambitions.

Do not be wedded to a given technology. 

During a Ph.D. or Post-Doc you spend a tremendous amount of time on a specific topic.  At the outset you may feel completely invested in your corner of the technology world and that you should pursue a career involving that technology. However, this can be very limiting and greatly reduce your opportunities for success.  Technology trends change constantly and what you picked 6 years prior may not be your best opportunity moving forward.  Once you publish your papers or submit your thesis, take this unique transition period to adjust what technologies or business area you want to spend the next 5-10 years.  Compare each potential area of interest as though you are making an investment (your career), and be prepared to defend your choice to your future self a few years out.

Want a job, create a company. 

Lastly, the best way to gather vast business, management, and leadership skills is to start your own venture.  Being a first time entrepreneur is akin to drinking from a firehose and this time will greatly accelerate your experience and perspectives on our industry. Starting a company may seem like a daunting endeavor, but considering the potential career upside, it is actually a pretty reasonable proposition. Even if you fail, you will learn a tremendous amount, meet a community of like-minded folks, and become comfortable with taking career altering risks.  I suggest spending at least an extra 6 months at your institution to find an idea with legs and try to get it off the ground. Don’t do any bench work at this time, but use the period to find and test the commercial viability of potential new ventures.  Be bold – talk to your tech transfer office to see if any technology is looking for a founder, ask professors to fund you from existing grants while you examine the commercial viability of a technology, join entrepreneur communities, attend founder speed-dating events, etc. And if you’re your venture doesn’t fly, this time is a drop in a bucket compared with the 6 years just spent padding your academic CV.

{ 2 comments }

Required Reading – Rusnano, Breakout Labs, VC, Burrill Report, etc.

October 30, 2011

Nanotech firms BIND and Selecta raise funds from Rusnano (here) Peter Thiel founds Biotech incubator Breakout labs (here) The ongoing plight of the VC industry (here) Podcast of Brad Feld of Foundry Group (here) The November 2011 Burrill Report (here)

Read the full article →

Share the Risk not the Channel and Sell, Sell, Sell

October 23, 2011

Traditionally, companies that supply equipment to scientific researchers have used direct sales to drive adoption and growth. For start-ups this would typically require a partnership with an established entity. But recently a new strategy has emerged where the web is used both to create buzz about a product, and as a channel to convert interest [...]

Read the full article →

Required Reading – Industrial Biology, DNAnexus, VC Barbells, etc.

October 19, 2011

California’s industrial biotechnology sector sees rapid growth (here) Google invests in DNAnexus for cloud based sequence data (here) The increasingly barbell nature of the VC industry (here) Corning’s surprisingly awesome video about glass (here)

Read the full article →

Is There Value in Debt for Early-Stage Technology Ventures?

October 13, 2011

Consider this scenario. You are an entrepreneur with an early-stage venture. Emerging from stealth mode, you make it your mission to speak to as many of the great and the good in the community to lay the groundwork for a future Series A financing. (Un)expectedly, someone immediately recognizes that after implementation of your technology – [...]

Read the full article →

Rough Few Months for DNA Sequencing Companies

October 11, 2011

It’s been a pretty rough ride for many of the life science tools companies, particularly for those involved in DNA sequencing. Illumina recently saw its share price tumble as sales plummeted in the third quarter (Reuters article). Illumina stated that the drop in sales was primarily due to uncertainty in the future levels of US and [...]

Read the full article →

Required Reading – FDA, Corporate VC, Getting Rich, Steve Jobs

October 6, 2011

The FDA (finally) incorporating innovation into their policy (here) Debunking corporate venture capital in biotech (here) The most patriotic thing you can do (here) Steve Jobs: How to live before you die (here)

Read the full article →

WSGR Fall 2011 Life Science Report

October 3, 2011

Wilson Sonsini Goodrich & Rosati (WSGR) recently released their semi-annual report on the Life Sciences (here).  Although a bit of an advert, the report is a worthwhile read with interesting insight and analysis on the industry.  Three articles in the report are particularly interesting: 1) Analysis of the recently legislated US Patent Reform, the “America [...]

Read the full article →

Required Reading – Startup Genome, Non-Dilutive financing, Premature Scaling, etc.

September 12, 2011

The Startup Genome Report (link) Video interview of super entrepreneur, Elon Musk (link) Zymeworks snags a $187M deal with Merck (link) Premature scaling in Biotech startups (link) Our post on sources of non-dilutive financing – part 1 (link, natbiotech_link)

Read the full article →